Pediatric Cardiology News

Despite low absolute rates, researchers observed elevated odds of cardiac injury among male adolescents and young adults after messenger RNA-based COVID-19 vaccination in a large U.S. study, as well as a smaller study in Hong Kong.

Arterial stiffness in adolescence may be a causal risk factor for hyperinsulinemia and insulin resistance in young adulthood, driving risk for incident type 2 diabetes, according to research published in Hypertension.

Most pediatric patients with multisystem inflammatory syndrome also had evidence of myocardial injury, but functional recovery was quick with no adverse coronary outcomes, researchers reported.

A global healthy lifestyle intervention initiated in preschool settings was associated with improved health knowledge, attitude and habits and could potentially reduce CVD risk across the life span, data from a 10-year review show.

Healio and Cardiology Today have aggregated a list of recent updates on the CV impact of COVID-19 infection and vaccination.

Among young patients with provoked venous thromboembolism, shorter duration of anticoagulation is noninferior to current standard of care, according to the results of the Kids-DOTT randomized trial.

Compared with surgical ligation, transcatheter closure of the patent ductus arteriosus in infants and neonates was associated with reduced mortality rates and lower length of stay, researchers reported.

As the COVID-19 pandemic continued to dominate the news, more was learned about its CV implications over the past year. However, the year also featured a number of important developments in other realms of cardiology.

The Children’s Heart Foundation announced it funded more than $1 million in congenital heart defects research and scientific collaborations in 2021.

At 10 years, transcatheter pulmonary valve replacement provided sustained symptomatic and hemodynamic improvement in most patients with complex congenital heart disease, data from the Melody investigational device exemption trial indicated.